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Varies with Adenosine Diphosphate Concentration
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ABSTRACT We have previously reported that maximal platelet activation with adenosine diphosphate (100 pM ADP) causes
rapid expression of all GPIlb-llla receptors for fibrinogen (FgR) (<1-3 s), measured with FITC-labeled PAC1 by flow cytometry.
We have extended these studies to examine the effects of ADP concentration on the graded expression and Fg occupancy of
GPIlb-lila receptors. Human citrated platelet-rich plasma, diluted 10-fold with Walsh-albumin-Mg+2 (2 mM), was treated with
ADP (0.1-100 pM). The rates of GPIlb-llla receptor expression or Fg binding were measured in unstirred samples by flow
cytometry, using FITC-labeled monoclonal antibodies (mAb) PAC1 and 9F9, respectively, from on-rates, using increasing times
between mAb and ADP additions. Fibrinogen receptors were all expressed rapidly at low (1 pM) or high (100 pM) ADP (few
seconds), whereas Fg occupancy was 50% of maximal by about 2 min. The maximal extent of GPIlb-lila receptor expression
and Fg occupancy was determined from maximal binding (Fmaj) at 30 min incubation with PAC1 or 9F9. On-rates and maximal
extents of binding for either PAC1 or 9F9 probes showed identical [ADP]-response profiles ("KD" 1.4 ± 0.1 pM). However,
F/max studies showed bimodal histograms consisting of "resting" (PO) and maximally "activated" (P*) platelets for both PAC1 and
9F9 binding, with the fraction of "activated" platelets increasing with ADP concentration. The data best fit a model where platelet
subpopulations are "quantally" transformed from P0 to P*, expressing all GPIlb-llla receptors, rapidly filled by Fg, but "triggered"
at critical ADP concentrations. Larger, but not the largest, platelets appear to be the most sensitive subpopulation. The im-
plications for clinical studies are discussed, and the relationship to dynamics of aggregation are described in a companion paper.
INTRODUCTION
Mammalian blood platelets circulate as inert, discoid cells
until activated by a variety of physiological agonists, includ-
ing adenosine diphosphate (ADP), thrombin, or collagen,
which all cause rapid shape changes (Frojmovic and Milton,
1982; Gear, 1984; Pedvis et al., 1988) and activation of
GPIIb-IIIa by altered conformation and/or microenviron-
ment in the membrane (Plow and Ginsberg, 1989; Shattil
et al., 1987; Shattil et al., 1989). Subsequent platelet aggre-
gation is generally considered to be mediated by fibrinogen
(Fg) binding to the activated GPIIb-IIIa complex (Marguerie
et al., 1980; Niewiarowski et al., 1983; Peerschke, 1985) with
ensuing cross-bridging of platelets, as shown schematically
in Fig. 1. It is expected that any mechanisms that increase the
number of fibrinogen receptors per unit area of membrane at
the site of bond formation will enhance rates and extent of
aggregation (Bell, 1988). Many studies have been reported
for ADP-induced macroaggregation using turbidimetrically
determined light transmission changes, suggesting that the
quantity of fibrinogen bound is related to the degree of plate-
let aggregation (Marguerie et al., 1980; Niewiarowski et al.,
1983; Peerschke, 1985): however, maximal ADP activation
and bulk, average Fg measurements using I125-Fg were gen-
erally made, with any subpopulation behavior undetected by
this approach.
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It is widely known that kinetics of platelet activation and
aggregation are markedly dependent on the concentration of
ADP as activator, as determined by direct particle counting
techniques, and on size and density-dependent subpopula-
tions (Carty and Gear, 1986; Frojmovic and Milton, 1982;
Frojmovic, 1994; Wong et al., 1989). We therefore opted to
evaluate the dynamics of GPIIb-IIIa receptor expression and
fibrinogen occupancy as a function ofADP concentration by
flow cytometry, which allows both rapid dynamical mea-
surements and detection of platelet subpopulation behavior
(Frojmovic et al., 1991; Frojmovic and Wong, 1991). We
recently reported a novel theoretical and experimental ap-
proach for measuring the rapid expression of activated
GPIIb-IIIa receptors for Fg on platelets maximally activated
with ADP (100 ,uM); we used the FITC-PAC1 monoclonal
IgM antibody, which binds specifically to the activated form
of the GPIIb-IIIa complex (Fig. 1). By measuring initial on-
rates of PAC1 binding, as a function of varying time interval
between ADP and reporting PAC1 addition, we discovered
that platelets appear to express maximally all of their GPIIb-
Illa receptors within 1-3 s ofADP addition (Frojmovic et al.,
1991), essentially poised for optimal rates of fibrinogen bind-
ing and rapid recruitment into aggregates. In addition, we
found that for maximal activation with ADP (100,uM), large
platelets expressed higher surface densities of GPIIb-IIIa re-
ceptors than did smaller platelets (Frojmovic and Wong,
1991), consistent with reported size-dependent subpopula-
tion responses of platelets to microaggregation (Wong et al.,
1989).
We have extended the above flow cytometric studies to an
analysis of the kinetics of expression of GPIIb-IIIa receptor
and its occupancy by fibrinogen as a function ofvaryingADP
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FIGURE 1 Schematic for glycopro- GP 11
tein fib-ia activation, fibrinogen bind-
ing, and fibrinogen-mediated platelet
aggregation. The resting platelet has GP
Ilb-IIIa randomly distributed in the
plasma membrane, unattached to cyto-
skeleton (CS), with negligible specific ^ Phy
affinity for soluble fibrinogen (Fg). Ac- Y ac
tivation with ADP generates signals
transforming GPIIb-ilIa into an acti- a118
vated receptdr that now expresses an ac-
cessible binding pocket for adhesive li-
gands including Fg; FITC-labeled
monoclonal antibodies PACl and 9F9 -
bind respectively to the activated, con- b \Z
formationally transformed GPIlb-HIa CS u*C
and Fg. Note that ligand-induced bind-
ing sites (LIBS) are shown for GPIIb- '17
Ila occupied by Fg (filled rectangles)
(4). The activated GPIlb-Ila is largely
"anchored" to cytoskeleton (CS),
whereas one or more Fg may cross-link aIb "a
two or more sets ofreceptors on adjacent
platelets.
concentration. We have used both FITC-PAC1, as well as
FITC-9F9, which reports specifically on Fg bound to its ac-
tivated GPIIb-IIIa receptor (Fig. 1) (Shattil et al., 1989). Ini-
tial on-rates for both probes were used to evaluate the rapidity
of receptor expression, whereas equilibrium binding mea-
surements were used to evaluate the maximal numbers per
platelet of free and Fg-occupied receptors for PAC1 and 9F9,
respectively. Our flow cytometric approach revealed that
(i) rapid expression of GPIIb-IIIa receptors occurs at varying
ADP concentrations, but (ii) subpopulation responses oc-
curred rather than a graded response of the entire platelet
population. Such a graded response to increasing ADP con-
centration might be expected from a model presenting a
pseudo-linkage between ADP binding to its receptor and
transformation of GPIIb-IIIa into an active receptor for spe-
cific binding of Fg (De Cristofaro et al., 1988). Thus, it ap-
pears that platelets are "quantally" transformed from "rest-
ing" cells (P°) to "maximally activated" cells (P*) with each
platelet "triggered" at a critical ADP concentration. In part
II, we demonstrate that the fraction of P* present at any given
ADP concentration corresponds to the actual platelet
number participating in rates and extent of platelet mi-
croaggregation (PA) for stirred platelet suspensions
(Frojmovic et al., 1994).
MATERIALS AND METHODS
Materials and chemicals
All chemicals and reagents, unless otherwise specified, were purchased from
Sigma Chemical Co. (St. Louis, MO). The platelet activators ADP was
diluted in Walsh buffer from a stock of 0.02 M (in Tyrode's pH 7.4) stored
at -20° celsius. The vehicle of additions of activator to 10-fold diluted
platelet-rich plasma was <10% (v/v). Fluorescein isothiocyanate (FITC;
Isomer I, on celite 10%) used for monoclonal antibody labeling was pur-
chased from Behring Diagnostics (La Jolla, CA). Aldehyde solutions used
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trisodium citrate was prepared from Sigma, whereas the fatty acid free
bovine serum albumin was prepared from ICN Biochemicals (Cleveland,
OH). ADP, or trisodium citrate (all from Sigma) or glutaraldehyde (8%
aqueous stock in sealed ampoules, Polysciences Inc., Warrington, PA) were
separately diluted in Ca2+/Mg2+-free Tyrode's solution (NaCl 140 mM, KCl
2.7 mM, NaHCO3 0.4 mM; pH 7.4). Walsh-albumin solution was freshly
made up as needed from Tyrode's containing Mg2" (2 mM), albumin (1
mg/ml) [bovine albumin, Fraction V (Sigma)], and glucose (1 mg/ml).
Monoclonal antibodies
PAC1, a murine monoclonal IgM antibody specific for GP IIb-Illa in its
activated state (Shattil et al., 1987, 1989), and 9F9, a murine monoclonal
IgG antibody specific for the D-domain of fibrinogen bound to its GPIIb-IIIa
receptor (Shattil et al., 1989), were purchased from Dr. Sanford Shattil
(University of Pennsylvania, Philadelphia, PA) and Dr. Andrei Budzynski
(Temple University, Philadelphia, PA), respectively. The antibodies were
conjugated with FITC (Shattil et al., 1985), and aliquoted stocks of this
material were stored at -700 celsius. On the day of use, these stocks were
freshly thawed and spun for 5 min at 8700 X g to remove antibody ag-
gregates. The fluorescein/protein (F:P) molar ratio varied between 7.0 and
7.7 for the three different preparations of FITC-PAC1 used, and from 2.9
to 3.6 for FITC-9F9.
Preparation of platelet-rich plasma
Healthy males and females, between the ages of 19 and 45 and not on any
medication, were used as donors with their informed consent. Blood was
collected from the antecubital vein by venipuncture. It was then added di-
rectly into 3.8% sodium citrate (1 vol to 9 vol blood), and platelet-rich
plasma (PRP) was prepared and maintained at 37°C for 30 min before use,
as previously reported (Frojmovic et al., 1991); the PRP was then diluted
10-fold (PRP (1:10)) with Walsh-albumin at room temperature. All studies
with PRP were made within 2-4 h of blood collection.
Platelet-rich plasma processing for activation and
flow cytometric measurements
Quench-dilution measurements for PAC1
As previously reported, samples typically consisted of 22.5 ,ul of PRP (1:
10), plus 2.5 ,ul of activator (ADP) added at room temperature to 12x75 mm
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for platelet fixation were freshly prepared by diluting 8% glutaraldehyde
solution 10-fold with double distilled de-ionized water. The anticoagulant
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polystyrene tubes for varying incubation times (T) before the addition of
FITC-antibody (4 Al). Saturating concentrations of antibody were used to
yield >90% of maximal fluorescence after 30 min incubation for maximally
activated platelets: typically 0.1 ,uM for PAC1. Samples were hand-swirled
rapidly for <1 s to ensure complete reagent mixing but negligible aggre-
gation, verified by direct microscopic counting. After incubating the above
PRP (1:10) with ADP and antibody for incubation times, T, varying from
5 s to 60 min, each sample was quench-diluted 10-fold with Walsh-albumin
and measured by flow cytometry within 30 s to minimize any post-dilution,
time-dependent changes as previously reported (Frojmovic et al., 1991).
These studies were performed for varying T at selected concentrations of
ADP (1, 10, or 100 ,uM). We confirmed our previous observations that
10-fold dilution of PRP (1:10) containing 100 ,uM ADP and FITC-PAC1
alters neither Flmn, (Frojmovic et al., 1991) nor the fraction of activated
platelets (P*) caused by dilution, whether activating with 100 or 1 ,uM ADP.
All of the above procedures were conducted at room temperature.
Direct measurements without dilution for 9F9
Samples were processed as in Quench-Dilution Measurements for PAC1
above, except that six volumes (typically 135 ,l) of PRP 1:10 was used for
direct measurements with the flow cytometer without any further sample
dilution to avoid underestimates caused by significant off-rates of 9F9 with
sample dilution. Typically, 0.6 ,uM 9F9 monoclonal antibody was used for
saturation conditions.
Flow cytometry measurements
Platelet samples were analyzed for 2500-5000 cells in a FACSCAN flow
cytometer (Becton-Dickinson Canada, Mississauga, Ontario). Light scatter
(forward scatter (FSC), side scatter (SSC)), and one color fluorescence (FL)
were obtained with flow cytometer gain settings in the logarithmic mode and
analyzed with Becton-Dickinson C30 software on a Hewlett-Packard 300
computer to yield cross-plots, histograms, or mean values, as previously
reported (Frojmovic et al., 1991). In the case of both unactivated and maxi-
mally activated platelets, the mean and mode values for Fl and FSC (forward
scatter) were within <5% of each other because of the symmetrical shapes
of the histograms. Fl values associated with FITC-antibody binding to ac-
tivated platelets were corrected for nonspecific or background binding by
subtracting Fl "control" values obtained in the absence of activator or by
the addition of 5 mM EDTA 10 s before addition of the activator. Thus,
parallel samples were incubated with PAC 1 or 9F9 for identical times
without activator, as for the activator studies, and background Fl values were
obtained.
Time courses of FITC-PAC1/9F9 binding were obtained for samples
pre-activated with ADP for different times, T, from the mean platelet-bound
fluorescence (Fl), determined for 215 s of antibody addition, as previously
reported (Frojmovic et al., 1991). Both rapid, initial rate of increase in
fluorescence (Fl) (related to antibody on-rates) and maximal extent of in-
crease (Fl,,,,) were thus determined for different T values. These measure-
ments yield the rate of formation of fibrinogen receptors (kl) and the maxi-
150
FIGURE 2 Dynamics of fluorescence histograms of
platelets maximally pre-activated with 100 ,uM ADP
(T = 3 s) with time-dependent binding of (A) FITC-
PAC1 and (B) FITC-9F9. From left to right, incubation
times with antibodies were as follows: (A) control,
30 s, 60 s, and 30 min and (B) control, 15 s, 30 s, and
30 min.
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mal number of free and fibrinogen-occupied receptors, respectively, for
PAC1 and 9F9, as a function of activator concentration and time of action
(Frojmovic et al., 1991).
For the ADP dose response studies, platelets were pre-activated for 3 or
10 s with varying ADP concentrations (specified in legends to figures), and
on-rates and maximal equilibrium binding (maximal extent; Flm,R ) of bind-
ing of PACI or 9F9 were respectively measured from Fl values determined
for 30 s and 30 min incubations with the reporting antibody.
For analyses of maximal, equilibrium binding of antibodies, Fl,, values
were analyzed by two different methods. One method, as used previously
for platelets maximally activated with 100 ,uM ADP (Frojmovic et al.,
1991), uses the mean value for the entire platelet population. A second
method is based on the observation that at high ADP concentrations most
of the platelets have Fl values greater than a critical threshhold value, Flc,
but decreasing fractions of these platelets remained above this threshhold
with decreasing ADP, i.e., there was a bimodal distribution of "resting" (PO)
and "maximally activated" (P*) platelets. For this type of subpopulation
analysis, we report the fraction of platelets having Fl > Fl,, i.e., the fraction
of "maximally activated" platelets as a function of varying ADP concen-
tration. Flc was experimentally selected such that >95% of all platelets had
Fl values <Flc in PRP 1:10 in the absence of added ADP.
RESULTS
Kinetics of binding of PACI and 9F9 to platelets
maximally activated with ADP
For platelets maximally pre-activated with 100 ,M ADP
(T = 3 s), a time course of FITC-PAC1 or 9F9 binding to
platelets was obtained by dilution-quenching or "live" mea-
surements, respectively, at t-values ranging from 0 to 30 min,
as shown for the fluorescence histograms in Fig. 2. There was
a net shift in fluorescence profiles to equilibrium, maximal
values within 30 min incubation (profiles were unchanged
for 45 and 60 min points, not shown) for both PACi and 9F9
binding, as previously reported for PAC1 (Frojmovic et al.,
1991).
We confirmed that Fl increased linearly with PAC1 in-
cubation times for varying T values after 100 ,uM ADP ad-
ditions as previously reported (Frojmovic et al., 1991) and
showed linear changes for 9F9 reporting on bound Fg for 100
,uM ADP (Fig. 3), allowing measures of on-rates and Flm,
(.30 min) for PAC1 or 9F9 for varyingADP concentrations.
The time needed for maximal expression of receptors at de-
creasing activating ADP concentrations needed first to be
determined.
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FIGURE 3 Kinetics of the increase in mean fluorescence (F1) of FITC-
9F9 to platelets maximally activated with lO0 ,uM ADP as a function of
increasing preactivation time T. The initial rate of increase in F1 represents
the 9F9 on-rate (v) for binding of the probe for time T. F1 values corrected
for nonspecific binding are shown for one of six donors evaluated. Linear
regression lines have been drawn for each set of data points, with r values
of 0.996, 0.997, and 0.935 for decreasing T.
Rapidity of expression of Fg receptors and of Fg
binding with varying ADP
We previously reported that activation of platelets with 100
,uM ADP (maximal activation) causes rapid expression of
all fibrinogen receptors within 3 s of activator addition
(Frojmovic et al., 1991). This was concluded from the ob-
servation that the same initial on-rate (v) for PAC1 binding
was seen for pre-activation times of 1, 3, or 10 s. We have
confirmed that rapid expression of fibrinogen receptors oc-
curs at decreasing ADP concentrations to 1 ,uM (Fig. 4 A)
with <10% differences between 0.5 and 1 ,uM ADP and 100
,uM ADP. The donor's platelets used for this study showed
a small delay for 100% activation of all GPIIb-IIIa compared
with the three donors previously reported (Frojmovic et al.,
1991), but >60-80% of all receptors were expressed within
3 s for 0.5-100 ,uM ADP evaluated, with :95% by I0 s. In
addition, as previously reported (Frojmovic et al., 1991),
Flm. values were independent of varying T values, even
though on-rates (v) did decrease with T beyond 1 min for
PAC1 binding (Fig. 4 A). This decay in accessibility of
the activated GPIIb-IIIa beyond 1 min-of ADP activation
occurred for the range of 0.5-100 ,uM evaluated, with 2
,uM ADP showing the same results as that reported for
100 ,uM ADP.
Fig. 3 shows linear increases for fluorescence for 9F9, with
incubation time of platelets after maximal activation with
100 ,LM ADP, out to 1 min, because more Fg will bind during
increasing T times between addition of ADP and final ad-
dition of the reporting 9F9 mAb. A plot of initial on-rate (VT)
as a function of T normalized to maximal vT values found for
T= 60 s, was previously shown to be a relative measure of
the number of fibrinogen receptors (FgR) using PAC 1 as the
reporting mAb (Frojmovic et al., 1991) and receptor acces-
sibility. A similar plot for receptors occupied by Fg and ac-
cessible to the reporting mAb at time T of addition of 9F9 has
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FIGURE 4 Relative on-rates (VT) of (A) FITC-PACl or (B) FITC-9F9 for
different periods of pre-activation (T) with varying concentrations of ADP.
The data have been normalized to vT-max values obtained for T s 60 s. One
representative donor is shown for PAC 1, and mean ± 1 SD for 4 ± 2 donors
are shown for 9F9.
been determined (Figs. 3 and 4 B). Analysis of such plots
obtained for both 100 ,iM and 1 ALM ADP as shown in
Fig.4 B, showed (i) similar initial rates of Fg-occupancy for
1 and 100 ,uM ADP, (ii) a half-time (tjt2) for maximal on-
rates for 9F9 binding to bound Fg of about 10 s, peaking at
about 60 s, with on-rates decaying by 5 and 15 min, as pre-
viously observed with PACI binding (Frojmovic et al.,
1991), whether activating with 1 or 100 ,uM ADP. The half-
Frojmovic et al. 2063
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time (t,,2) for maximal occupancy by Fg is 2 ± 0.5 min,
measured from Flm. values as shown in Fig. 2 for 100 ,uM
ADP, with data pooled and analyzed for three donors, yield-
ing a plot from which the time for 50% of Flmaxto be reached
could be graphically determined as t1/2. Note that the same
Flm. values were obtained for varying T (as previously re-
ported for PAC1) (Frojmovic et al., 1991).
Dependence of PAC1 and 9F9 binding (rates and
extent) on ADP concentration used for
activating platelets
A series of fluorescence histograms were next obtained as
shown in Fig. 2 for 100 ,uM but now determined for con-
centrations of ADP varying from 0.1 to 100 ,uM, with pre-
activation times of 3 s: such a series of histograms is shown
for Fl measured for 30 s incubation of platelets with PAC1
and 9F9 chosen to reflect initial on-rates (vT) (Fig. 5). A plot
of mean Fl values, determined from profiles as shown in
Fig. 5, but determined for pre-activation times of 10 s to
ensure maximal receptor expression, was then obtained to
show the time-dependence for PAC1 or 9F9 binding to plate-
lets for different ADP activator concentrations. It is seen that
Fl varies linearly with time over the first 30 s of PAC in-
cubation (Fig. 6), such that initial on-rates (v) can faithfully
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FIGURE 6 Dependence of the initial rate of binding of PACI to platelets
activated with varying ADP concentration. Corrected Fl values versus in-
cubation time with FITC-PAC1 are shown for one typical donor from a pool
of 10 donors. Similar curves were obtained with 9F9 for five donors. The
initial slopes represent on-rates (v), determined from Fl values at 30 s, as
reported in Fig. 7.
be obtained fom 30 s measurements of Fl. Similar results
were obtained for 9F9 (data not shown). A plot of the initial
rate of increase in specific Fl due to PAC1 or 9F9 binding
determined from these curves (v) as a function of ADP con-
centration (Fig. 6) yields similar log-dose-response curves
(Fig. 7).
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FIGURE 5 Fluorescence profiles for the effect of varying the ADP con-
centration on the binding of (A) FITC-PACt (reflecting fibrinogen receptor
expression) and (B) of FITC-9F9 (fibrinogen binding), measured during the
initial linear phase of binding (for T = 3 s, t = 30 s). These mean fluo-
rescence values are used to represent initial on-rates (v).
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FIGURE 7 Log dose-response curves for the relative on-rates and maxi-
mal extent of PACl or 9F9 binding for platelets activated with increasing
ADP concentrations. Fluorescence parameters have been normalized to
maximal values obtained at 100 ALM ADP. Platelets were pre-activated with
varying ADP for l0 s (T value). On-rates were determined for 30 s antibody
incubation (linear portion as in Fig. 6) with relative mean ± SD shown for
each antibody for three donors. Maximum fluorescence (Fl) values were
obtained for 30 min incubations with antibody, with the mean Fl values
recorded for the entire platelet population, irrespective of apparent sub-
populations shown in Fig. 8 (see Materials and Methods); relative mean
values are shown for 10 and 5 donors, respectively, for PACI and 9F9, with
plus and minus standard SDs, respectively, shown for 9F9 and PACt for
filled symbols (very similar SDs were obtained for the open symbols).
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A series of fluorescence profiles were also obtained to
compare the maximal extent of fluorescence obtained with
various concentrations of ADP using both FITC-9F9 and
FITC-PAC1 (Fig. 8) reporting on the extent of fibrinogen
receptor expression and of fibrinogen binding, respectively.
For both probes, the maximal extent of specific binding
was observed for 10-100 ,uM ADP. However, it must be
noted that unlike the Fl profiles shown for early binding
times (Fig. 5), corresponding to initial on-rates (v), the Fl
histograms at equilibrium, maximal binding show evidence
of at least two distinct subpopulations of cells. We therefore
conducted the following two types of analyses of the data:
(i) measurement of the mean fluorescence values (Fl) for the
entire population, neglecting the possibility of subpopulation
behavior, and (ii) measurement of the percent of cells with
fluorescence values above a critical threshold (Fl), deter-
mined from the apparent shift of most cells to one uniform
histogram at maximal ADP activation. Log-dose-response
curves are shown for Flm. vs. [ADP] for both PAC1 and 9F9
binding, determined from overall mean Fl values (Fig. 7).
Log-dose-response curves for both v and Flmu show that
similar sensitivity to ADP was observed for the expression
FITC-PAC1
T=3s; t=30 min
of
cells
100
of fibrinogen receptors whether determined from on-rates (v)
or Flm. for FITC-PAC1 binding, or whether using 9F9 or
PAC1 as the reporting probes (Fig. 7). The percent of cell
with Fl > Fl, was also found to yield identical log dose-
response curves for PAC1 and 9F9 for Fl or for relative
percent of activated cells, shown for data using FITC-9F9 as
the reporting probe (Fig. 9). Similar threshold values were
observed whether examining fibrinogen receptor expression
or Fg binding as determined from both on-rates and maximal
extent, typically 0.2-0.3 ,uM ADP. The ADP concentrations
causing 50% of maximal increases in the above parameters,
[ADP],,2values, in all cases were 1.3 ± 0.3 ,uM (range 0.9-
1.6 ,M). In addition, it appears tht mean Flm. values are
exact predictors of the relative percent of activated platelets
(percent of cells above a critical threshold seen in Fig. 8). We
therefore next examined the quantal nature of resting P0 to
activated P* transformation.
"Quantal" activation of platelets
We found that "activated" (P*) and "resting" (P°) platelets
displayed distinct and constant values of Flm. (Fig. 10).
Thus, the mean maximal fluorescence for "resting" platelets
(FP) incubated with PAC1 or 9F9 changed very little over
the entire range of cell activation as the percent of such cells
decreased from >95% to <10-20% (Fig. 10). There appears
to be an effective "quantal" activation from P0 to P* cells
expressing maximal PAC1 or 9F9, with the percent of such
cells driven by the ADP concentration. In contrast to the
minor changes in Flovalues with varying percent of activated
cells, it is seen that Fl* increased by 1.7-fold for Fl* values
A
[ADP]gM
1.0
0.8
0
%..
Pk
a
to
IdB
0.6
0.4
0.2
of
cells
[ADP]JM
10
104 0
FIGURE 8 Fluorescence profiles for maximal equilibrium binding of
(A) FITC-PAC1 and (B) FITC-9F9, to platelets pre-activated for 3 s with
varying ADP concentrations and then incubated with the antibody for 30
min. Data are for one typical donor. Note subpopulation responses. No
differences were observed whether preactivating for 0 or 10 s.
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FIGURE 9 Comparison of the ADP concentration dependence of the
overall mean fluorescence (Fl) for maximal binding of FITC-9F9 (disre-
garding subpopulation behavior) to the percent of cells "quantally" activated
(P* with Fl > Fl, (see Fig. 8 and Materials and Methods)). Fl and % cells
Fl > Fl, have been normalized to 1 for 100 ,uM ADP, with the mean shown
for the same four donors studied in parallel for each of the two parameters;
plus and minus SD bars are respectively shown for the open and filled
symbols, except for the data at 10 ALM ADP (one donor). Spline curves were
drawn by running interpolation of cubic polynomials. Similar results were
obtained with FITC-PAC1 as the reporting probe.
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FIGURE 10 Dependence of the mean fluorescenc
and "activated" (Fl*) platelet subpopulations on the '
in the "resting" or "activated" state, shown for both
reporting probes. Fl' and Fl* were obtained by gatir
lations shown in Fig. 8 (see Materials and Methods),
ADP concentrations that determine the actual % of
second Fl profile corresponding to quantally activate
represents a distinct donor's PRP evaluated for both
of five donors and (B) four of four donors.
A are all transformed into high affinity receptors for fibrinogen,
as probed by the PAC1 IgM monoclonal antibody and rapid
flow cytometric measurements, within seconds of ADP
addition to the platelets in platelet-rich plasma (PRP)
(Frojmovic et al., 1991). We have now confirmed this rapid
expression of receptors for varying ADP concentrations
using PAC1 as reporting probe. Thus, 67 to >80% of maxi-
mal on-rates for either probe were obtained within seconds
, ' of ADP addition for ADP concentrations varying from <1-
100 ,uM ADP (Fig. 4). The somewhat "apparently" slower
expression at 0.5-1 ,uM ADP ('10% slower over the first
Fl° 10 s) compared with 100 ,uM ADP may arise from the het-
erogeneous response of platelets, yielding mean fluorescence
values (Fl) consisting of both "resting" (P°) and "activated"
(P*) platelets, discussed below in greater detail.
We have also confirmed, for both PAC1 and 9F9 probes,
that the accessibility of the activated GPIIb-IIIa receptor to70 80 90 100 the IgM PACI, or to 9F9 IgG binding to Fg, measured from
on-rates of these probes, decreases between 1 and 15 min
after ADP binding for varying ADP concentrations; this was
B previously reported for PACI binding to platelets activated
with 100 ,uM ADP (Frojmovic et al., 1991). In all cases, as
previously reported, maximal, equilibrium fluorescence val-
ues (Flm.) were unaffected with varying incubation times, T,
between ADP and reporting probe additions. Finally, the
measured t1/2 of about 2 min for Fg occupancy in PRP (1:10)
is comparable with that reported elsewhere using I125-Fg
(Plow and Marguerie, 1980) or FITC-labeled Fg (Xia and
Frojmovic, 1994).
Fluorescence profiles for early binding times of PACI or
9F9 to platelets activated with 1-100 ,uM ADP show broad
distributions with suggestions of "shouldering" and sub-
population responses (Fig. 5). Equilibrium binding studies
; =~Z~O~p4J showed unequivocally for either probe that platelets appear
to be transformed "quantally" from "resting" (P°) to "acti-
vated" (P*) platelets, increasing with more elevated concen-
70 80 90 100 trations of ADP. Both on rates (v) and Flm. values for mean
Fl used without accounting for subpopulation responses, var-
ied identically with [ADP], as well as with the actual percent
e for the "resting" (FP) of P* measured from equilibrium binding as a function of
% of cells, respectively, ADP. This is most simply explained by the fact that Fl values
(A) PAC1 and (B) 9F9 are likely
A^tV FISA +arerig on tne two sunpopu-
as a function of varying
all cells present in the
ed platelets. Each curve
Fl and FI* in (A) four
for .80% activated cells vs. '20% of activated cells (SD ±
0.3 and 0.6 for 9F9 and PAC1, respectively, for the data
shown in Fig. 10).
DISCUSSION
We previously reported that the resting GPIIb-IIIa com-
plexes on platelets maximally activated with ADP (100 ,uM)
Fl = f°Fl + f*FI *,
where fo and f* are the fraction of resting and activated
platelets with mean fluorescence Fl° and Fl*, respectively.
Therefore,
Fl = Fl0 +f*(Fl* - Fl°) = a + bf*
where Flo and Fl* are considered constants for "resting" and
quantally activated platelets, i.e., Fl values directly predict
f*, the fraction of activated cells, as shown experimentally
(see Fig. 9). This relationship is expected to apply equally to
early on-rate measurements, consistent with results showing
identity between the ADP concentration-dependence for on-
rates and Flmax*
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Analysis of the data shown in Fig. 10 for "resting" (P°)
versus "maximally activated" (P*) platelets shows that FP0
are less than 5% of Fl* values, but Fl* increases with the
fraction of P*: Fl* for 80% P* is 1.7 times greater than Fl*
for only 20% P*. This increase in Fl* values occurring with
increasingADP could be largely associated with larger plate-
let size and mean surface area (SA) and/or higher surface
density of receptors. Thus, if the first 20% of activated plate-
lets were the largest platelets, predicted from the reported
greater sensitivity of larger platelets to aggregation (Wong
et al., 1989), then Fl*(0.8)/F1*(0.2) would be expected to be
<0.7 rather than the observed 1.7. However, analyses of the
forward scatter (FSC) profile for the 20% P* formed at the
lowest ADP show these platelets to have only intermediate
to higher FSC values compared with the resting population
(data not shown), consistent with intermediate-larger sized
platelets (Frojmovic and Wong, 1991), i.e., the largest plate-
lets do not appear to be exclusively recruited at the low ADP
concentrations associated with formation of 20% P*. In ad-
dition, it was found that the width of the histograms for Fl*
actually decreased by 22 ± 13% for PAC1 and 9F9 as the
percent of P* increased from 20 to .80%. Therefore, the
increase in Fl* with increasing percent of P* largely reflects
parameters other than size, such as heterogeneity in platelet
production and platelet age (Carty and Gear, 1986; Corash
and Gralnick, 1977; Frojmovic and Milton, 1982; Penington
et al., 1976; Wong and Frojmovic, 1989).
The subpopulation response (P0 and P*) associated with
expression of the GPIIb-IIIa receptor and its occupancy by
Fg has never been observed for a-granule secretion of GMP-
140 or GPIIb-IIIa, i.e., there is an ADP dose-dependent but
unimodal increase in fluorescence for antibody probes re-
porting on a-granule secretion (S12 mAb for GMP 140) or
GPIIb-IIIa secretion (AP2), with all of the platelets respond-
ing in a graded fashion (data not shown). The -20% of
platelets remaining as "resting" P°, with respect to PAC1 and
9F9 binding, up to 100 ,uM ADP, are expected to undergo
the partial secretion observed homogeneously for the entire
platelet population.
The support for ADP-driven "quantal" activation of plate-
let subpopulations can be found upon careful analysis of
histograms published by Warkentin et al. (1990) for FITC-
labeled polyclonal antifibrinogen antibody binding at equi-
librium conditions (30 min) to platelets in anticoagulated
blood activated with varying ADP concentrations. Jackson
and Jennings (1989), using a similar approach with plasma
diluted PRP, found that the proportion of platelets "showing
positive antifibrinogen antibody binding" increased with
ADP concentration, but they did not quantitate the "cutoff"
for positive cells, and additionally observed a more than four-
fold increase in Fl for the "positive" platelets with increasing
ADP concentration. The capacity for platelets to respond in
an "all or none" fashion has been reported for calcium tran-
sients occurring maximally in a subpopulation of platelets:
77-86% of all cells responding over a 20-fold increase in
thrombin concentrations (Davies et al., 1990). Changes in
calcium are expected to be related to fibrinogen receptor
expression in the responding platelet subpopulations (Kroll
and Schafer, 1989).
It has been proposed that GPIIb-IIIa is conformationally
transformed from a low affinity state (T) to a high affinity
state (R) capable of specific binding of adhesive proteins
such as Fg, via pseudo-linkage between ADP receptor bind-
ing and Fg binding via a third component yet to be charac-
terized (De Cristofaro et al., 1988). Such a model could allow
for (i) a continuous, graded expression of receptor R on each
platelet with increasing ADP receptor occupancy or (ii) and
"all-or-none" response occurring above a critical ADP re-
ceptor occupancy varying for platelet subpopulations. Our
data favor the second possibility, although De Cristofaro
et al. (1988) could only interpret their data in terms of bulk,
average measurement, because they used 1"-I-Fg for mea-
suring Fg binding to platelets.
Increasing numbers of investigators are using fluorescent
probes in the clinical setting for detection of platelet acti-
vation in vivo (Abrams and Shattil, 1991; Ault et al., 1989;
Frojmovic, 1995; Ginsberg et al., 1990; Plow and Ginsberg,
1989; Scharf and Clemetson, 1995; Shattil et al., 1987;
Warkentin et al., 1990). Because "irreversibly" bound Fg can
inhibit the binding of PAC1 to activated platelets (Shattil
et al., 1987), both PAC1 and a monoclonal antibody to
receptor-bound Fg, such as 9F9, should be used to detect free
and occupied activated GPIIb-IIIa. Our studies underline the
power and sensitivity of flow cytometry for the detection of
only a few percent of circulating, activated platelets, as first
suggested by Shattil et al. (Shattil et al., 1987), given that low
activator concentrations do not yield "partially" activated
platelets, but rather a small fraction of readily detected, fully
activated P*.
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